MyAverix Finance
F · Healthcare
BRITANNIA LIFE SCIENCES (L020)
Biotechnology
BRITANNIA LIFE SCIENCES (L020) is listed on F in the Healthcare sector. Industry: Biotechnology. As of 2026-03-29, reported market cap is $9.66M, P/E ratio is 1.05, net margin is 12,993.7%. Use this page for a quick overview, then open the MyAverix Finance app for income statements, balance sheet, cash flow, and news.
Key metrics for L020
BRITANNIA LIFE SCIENCES (L020) — FAQ
What is BRITANNIA LIFE SCIENCES's market cap?
BRITANNIA LIFE SCIENCES (L020) has a reported market cap of $9.66M (data as of 2026-03-29).
What is L020's P/E ratio?
The price-to-earnings (P/E) ratio for BRITANNIA LIFE SCIENCES (L020) is 1.05 (data as of 2026-03-29).
Does BRITANNIA LIFE SCIENCES pay a dividend?
Dividend yield is not available in the current snapshot for BRITANNIA LIFE SCIENCES (L020). Check the MyAverix Finance app for the latest dividend data.
What sector is BRITANNIA LIFE SCIENCES in?
BRITANNIA LIFE SCIENCES (L020) is classified in the Healthcare sector (Biotechnology industry).
What exchange is L020 listed on?
L020 is listed on F.
What is BRITANNIA LIFE SCIENCES's net margin?
BRITANNIA LIFE SCIENCES (L020) reports a net margin of 12,993.7% (data as of 2026-03-29).
Full report in the app
Get the full report in the MyAverix Finance app — income, balance sheet, cash flow, ratios, and multi-year trends in one place.